Tecovirimat 200 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 200 mg
Reference Brands: TPOXX (USA), Tecovirimat SIGA (EU),
Category: Anti Viral
Tecovirimat (also known as TPOXX or ST-246) is FDA-approved for the treatment of human smallpox disease caused by Variola virus in adults and children.
Product Description:
Tecovirimat, marketed under the brand name TPOXX, is an antiviral medication with specific activity against orthopoxviruses, including smallpox and mpox. It made medical history in 2018 as the first antipoxviral drug approved in the United States, representing a major advancement in the treatment and preparedness for orthopoxvirus infections. Tecovirimat is designed to prevent the spread of virus within the body rather than directly killing the virus.
The drug works by inhibiting a viral protein involved in cellular transmission, effectively blocking the virus’s ability to exit infected cells and spread to healthy cells. This mechanism helps limit disease progression and supports the immune system in controlling the infection. Tecovirimat has demonstrated strong effectiveness in laboratory and animal studies, providing protection against infections such as mpox and rabbitpox.
Clinical experience has shown that tecovirimat is generally well tolerated in humans, with no serious side effects reported in studies. It was first used for human treatment in December 2018 following a laboratory-acquired vaccinia virus infection. Tecovirimat remains a critical therapeutic option for managing orthopoxvirus infections and enhancing global public health preparedness.
Tecovirimat — third party manufacturing & bulk supply
Tecovirimat 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tecovirimat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tecovirimat →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tecovirimat is used to treat smallpox and other orthopoxvirus infections. It works by inhibiting a viral protein essential for the formation and release of infectious virus particles, thereby limiting the spread of the virus in the body.
Tecovirimat is made from the antiviral compound tecovirimat (also known as ST-246), a small-molecule inhibitor targeting the orthopoxvirus VP37 envelope protein.
The well-known trade name is TPOXX.
TPOXX is manufactured by SIGA Technologies.
The generic name is tecovirimat.
The primary brand name is TPOXX.
It is manufactured in approved facilities in the USA, with some production also licensed to other regions depending on distribution agreements.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
